Science A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
2021
science
Science A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
2021
science
Science A new paper from EMBL’s Savitski team and Typas group describes their work on E. coli and how it brings a greater understanding of the way genes function and interact.
2020
science
Science EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells
2020
science
Science EMBL scientists identify drug targets in blood and organs
2020
science
Science Scientists develop technology to measure how ATP concentration affects protein solubility in cells
2019
science
Science EMBL scientists uncover large solubility and thermal stability changes of proteins during the cell cycle
2018
science
Science Scientists at EMBL and Cellzome develop technology to monitor the effects of drug treatments on protein degradation and synthesis
2018
science
Science EMBL scientists create a turnover catalogue of almost 10.000 proteins from primary cells
2018
science
Science Side-effects of leukaemia drug explained, reveal possibility of repurposing to treat other diseases
2016
science
Science New head of Proteomics Core Facility also runs stability proteomics lab
2016
science
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive